Author:
Tang Nelson L. S.,Liao Chen Di,Wang Xingyan,Mo Frankie K. F.,Chan Vicky T. C.,Ng Rita,Pang Elizabeth,Suen Joyce J. S.,Woo Jean,Yeo Winnie
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Oncology,General Medicine
Reference38 articles.
1. Anglicheau D, Legendre C, Beaune P, Thervet E (2007) Cytochrome P450 3A polymorphisms and immunosuppressive drugs: an update. Pharmacogenomics 8(7):835–849
2. Barrett JC, Fry B, Maller J, Daly MJ (2005) Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 21(2):263–265. doi: 10.1093/bioinformatics/bth457
3. Beith J, Goh B, Yeo W, Sullivan A, Lim S, Zhong S, Rivory L (2002) Interethnic differences in the myelotoxicity of adriamycin/cyclophosphamide (AC) for adjuvant breast cancer. In: Proceedings of American Society of Clinical Oncology Annual Meeting: J Clin Oncol 21:64a, #252
4. Bray J, Sludden J, Griffin MJ, Cole M, Verrill M, Jamieson D, Boddy AV (2010) Influence of pharmacogenetics on response and toxicity in breast cancer patients treated with doxorubicin and cyclophosphamide. Br J Cancer 102(6):1003–1009
5. Chew HK, Doroshow JH, Frankel P et al (2009) Phase II studies of gemcitabine and cisplatin in heavily and minimally pretreated metastatic breast cancer. J Clin Oncol 27(13):2163–2169
Cited by
26 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献